Phlebotomy 2011: Innovations in Quality, Service and Patient Care
October 6-7, 2011
Kahler Grand Hotel
Rochester, Minnesota
Faculty
COURSE DIRECTORS
Linda K. Iverson, CLPlb(NCA)
Laboratory Service Support
Department of Laboratory Medicine and Pathology
Mayo Clinic Rochester
Mary Kaye Peterson, M.Ed., CPT (NHA)
Phlebotomy Technician Program Director
Mayo School of Health Sciences
Phlebotomy Education Coordinator
Department of Laboratory Medicine and Pathology
Mayo Clinic Rochester
Sharon R. Wiesner, BS, CLPlb(NCA)
Operations Manager
Department of Laboratory Medicine and Pathology
Mayo Clinic Rochester
MAYO CLINIC ROCHESTER FACULTY
Michael Baisch
Systems Engineer II
Department of Laboratory Medicine and Pathology
Deana Burrill Chupp
Learning and Development Consultant
Human Resources Education and Development
Walter J. Cook, M.D.
Consultant, Community Pediatric and Adolescent Medicine
Assistant Professor of Pediatrics
College of Medicine, Mayo Clinic
Deb Hagen-Moe M.Ed.
Education Coordinator
Department of Laboratory Medicine and Pathology
James S. Hernandez, M.D.
Consultant, Laboratory Medicine
Assistant Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Mayo Clinic Arizona
Gayle Jones
Performance Management Consultant
Laboratory Medicine and Pathology
Brad S. Karon, M.D., Ph.D.
Consultant, Division of Clinical Core Laboratory Services
Department of Laboratory Medicine and Pathology
Associate Professor of Laboratory Medicine and Pathology
College of Medicine, Mayo Clinic
Martha Siska, R.N.
Infection Prevention and Control RN BSN
Nursing Services-Infection Prevent and Control
GUEST FACULTY
Anna Maravelas
Licensed Psychologist, M.A.
Founder, Thera Rising, Inc.
Author of “How to Reduce Workplace Conflict and Stress” (Career Press)
St. Paul, Minnesota
Father Nicklas Mezacapa
Motivational Speaker
Rector of Calvary Episcopal Church
Rochester, Minnesota
Faculty Disclosure
As a provider accredited by ACCME, Mayo Clinic (Mayo School of CME) must ensure balance, independence, objectivity, and scientific rigor in its educational activities. Thus, safeguards against commercial bias have been put in place. Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Faculty also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of this information will be published in course materials so that participants in the activity may formulate their own judgments regarding the presentation.


